Ultromics
Founded 2017 · 84 employees on LinkedIn · 8 known investors
Find your way into Ultromics
205 people in our graph share verified history with the Ultromics team — schools, employers, funds. One of them is your warm intro.
Tess van Stekelenburgunlockedknows Ross Upton · together at University of Oxford (overlapped)
×6knows the team · via University of Oxford
×5knows the team · via The National Institutes of Health
Ultromics develops AI models that analyze routine echocardiography studies to help clinicians detect HFpEF and screen for cardiac amyloidosis, delivered through a single workflow platform. Its findings integrate into existing PACS, CVIS, and EMR systems via standard DICOM routing for hospitals and echo labs.
Founders & leadership
Ultromics was founded in 2017 by Ross Upton.
RU
Ross UptoninFounder & CEORoss Upton is founder and CEO of Ultromics, which builds AI models to detect heart failure and cardiac amyloidosis from echocardiography scans. He is a clinical researcher at the University of Oxford and serves as AI co-chair for HeartShare at the NIH.
Investors · 8
Funding
SEC filings, press & company announcementsSource: company announcements and press reports — follow each round's link for the claim.
Founder mafia
3 people who came through Ultromics went on to found or lead other companies.
In the news
Frequently asked questions
- What does Ultromics do?
- Ultromics develops AI models that analyze routine echocardiography studies to help clinicians detect HFpEF and screen for cardiac amyloidosis, delivered through a single workflow platform. Its findings integrate into existing PACS, CVIS, and EMR systems via standard DICOM routing for hospitals and echo labs.
- Who founded Ultromics?
- Ultromics was founded by Ross Upton in 2017.
- Who are Ultromics's investors?
- Ultromics's investors include GV (Google Ventures), Oxford Science Enterprises, Legal & General, Future Planet Capital, Nina Capital, NovaCapital, Optum Ventures, ALLEGIS CAPITAL.